Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2026-03-01 @ 3:53 PM
Study NCT ID:
NCT07266766
Status:
COMPLETED
Last Update Posted:
2025-12-05
First Post:
2025-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg
Sponsor:
Humanis Saglık Anonim Sirketi
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Type 2 Diabetes Mellitus (T2DM) | View |
Keywords: